EPZM Annual Operating Profit
-$237.99 M
-$12.58 M-5.58%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual operaing income is -$237.99 million, with the most recent change of -$12.58 million (-5.58%) on December 31, 2021. During the last 3 years, it has fallen by -$109.89 million (-85.78%).EPZM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly Operating Profit
-$29.84 M
+$21.05 M+41.37%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly operating income is -$29.84 million, with the most recent change of +$21.05 million (+41.37%) on June 30, 2022. Over the past year, it has increased by +$28.40 million (+48.77%).EPZM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM Operating Profit
-$196.15 M
+$28.40 M+12.65%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM operating income is -$196.15 million, with the most recent change of +$28.40 million (+12.65%) on June 30, 2022. Over the past year, it has increased by +$42.97 million (+17.97%).EPZM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.6% | +48.8% | +18.0% |
| 3 y3 years | -85.8% | +41.2% | -10.7% |
| 5 y5 years | -73.9% | -4.8% | -10.7% |
EPZM Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | >+9999.0% | -283.6% | -5307.1% |
Epizyme Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$29.84 M(-41.4%) | -$196.15 M(-12.6%) |
| Mar 2022 | - | -$50.89 M(-0.8%) | -$224.55 M(-5.7%) |
| Dec 2021 | -$237.99 M(+5.6%) | -$51.29 M(-20.0%) | -$238.05 M(-4.4%) |
| Sept 2021 | - | -$64.14 M(+10.1%) | -$248.91 M(+4.1%) |
| June 2021 | - | -$58.24 M(-9.5%) | -$239.12 M(+0.3%) |
| Mar 2021 | - | -$64.38 M(+3.6%) | -$238.45 M(+5.8%) |
| Dec 2020 | -$225.42 M(+27.3%) | -$62.15 M(+14.3%) | -$225.42 M(+2.1%) |
| Sept 2020 | - | -$54.35 M(-5.6%) | -$220.76 M(+8.0%) |
| June 2020 | - | -$57.57 M(+12.1%) | -$204.36 M(+3.5%) |
| Mar 2020 | - | -$51.35 M(-10.7%) | -$197.50 M(+11.5%) |
| Dec 2019 | -$177.14 M(+38.3%) | -$57.49 M(+51.5%) | -$177.14 M(+23.1%) |
| Sept 2019 | - | -$37.95 M(-25.1%) | -$143.96 M(-0.4%) |
| June 2019 | - | -$50.70 M(+63.6%) | -$144.56 M(+16.5%) |
| Mar 2019 | - | -$30.99 M(+27.5%) | -$124.12 M(-3.1%) |
| Dec 2018 | -$128.10 M(-6.4%) | -$24.31 M(-36.9%) | -$128.11 M(-9.2%) |
| Sept 2018 | - | -$38.55 M(+27.4%) | -$141.16 M(+0.4%) |
| June 2018 | - | -$30.26 M(-13.5%) | -$140.66 M(+1.3%) |
| Mar 2018 | - | -$34.98 M(-6.4%) | -$138.86 M(+1.5%) |
| Dec 2017 | -$136.84 M | -$37.36 M(-1.8%) | -$136.84 M(+1.4%) |
| Sept 2017 | - | -$38.05 M(+33.7%) | -$134.96 M(+10.9%) |
| June 2017 | - | -$28.46 M(-13.7%) | -$121.74 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$32.96 M(-7.1%) | -$121.68 M(+8.8%) |
| Dec 2016 | -$111.83 M(-15.6%) | -$35.48 M(+42.9%) | -$111.83 M(+13.4%) |
| Sept 2016 | - | -$24.83 M(-12.6%) | -$98.62 M(+1.8%) |
| June 2016 | - | -$28.40 M(+22.9%) | -$96.90 M(+2.8%) |
| Mar 2016 | - | -$23.11 M(+3.7%) | -$94.29 M(-28.9%) |
| Dec 2015 | -$132.55 M(+140.8%) | -$22.28 M(-3.6%) | -$132.55 M(+5.7%) |
| Sept 2015 | - | -$23.11 M(-10.4%) | -$125.36 M(+2.8%) |
| June 2015 | - | -$25.79 M(-58.0%) | -$121.99 M(+11.4%) |
| Mar 2015 | - | -$61.38 M(+306.7%) | -$109.52 M(+98.9%) |
| Dec 2014 | -$55.05 M(+1660.5%) | -$15.09 M(-23.5%) | -$55.05 M(+132.2%) |
| Sept 2014 | - | -$19.74 M(+48.3%) | -$23.70 M(+73.1%) |
| June 2014 | - | -$13.31 M(+92.6%) | -$13.70 M(+434.6%) |
| Mar 2014 | - | -$6.91 M(-142.5%) | -$2.56 M(-18.1%) |
| Dec 2013 | -$3.13 M(+307.2%) | $16.25 M(-267.1%) | -$3.13 M(-86.9%) |
| Sept 2013 | - | -$9.73 M(+346.8%) | -$23.92 M(+145.4%) |
| June 2013 | - | -$2.18 M(-70.9%) | -$9.75 M(+252.6%) |
| Mar 2013 | - | -$7.48 M(+64.9%) | -$2.76 M(+259.9%) |
| Dec 2012 | -$768.00 K(-96.3%) | -$4.54 M(-202.1%) | -$768.00 K(-120.4%) |
| Sept 2012 | - | $4.44 M(-7.5%) | $3.77 M(-657.2%) |
| June 2012 | - | $4.80 M(-187.7%) | -$676.00 K(-87.7%) |
| Mar 2012 | - | -$5.48 M | -$5.48 M |
| Dec 2011 | -$20.97 M | - | - |
FAQ
- What is Epizyme annual operaing income?
- What is the all time high annual operating profit for Epizyme?
- What is Epizyme annual operating profit year-on-year change?
- What is Epizyme quarterly operating income?
- What is the all time high quarterly operating profit for Epizyme?
- What is Epizyme quarterly operating profit year-on-year change?
- What is Epizyme TTM operating income?
- What is the all time high TTM operating profit for Epizyme?
- What is Epizyme TTM operating profit year-on-year change?
What is Epizyme annual operaing income?
The current annual operating profit of EPZM is -$237.99 M
What is the all time high annual operating profit for Epizyme?
Epizyme all-time high annual operaing income is -$768.00 K
What is Epizyme annual operating profit year-on-year change?
Over the past year, EPZM annual operaing income has changed by -$12.58 M (-5.58%)
What is Epizyme quarterly operating income?
The current quarterly operating profit of EPZM is -$29.84 M
What is the all time high quarterly operating profit for Epizyme?
Epizyme all-time high quarterly operating income is $16.25 M
What is Epizyme quarterly operating profit year-on-year change?
Over the past year, EPZM quarterly operating income has changed by +$28.40 M (+48.77%)
What is Epizyme TTM operating income?
The current TTM operating profit of EPZM is -$196.15 M
What is the all time high TTM operating profit for Epizyme?
Epizyme all-time high TTM operating income is $3.77 M
What is Epizyme TTM operating profit year-on-year change?
Over the past year, EPZM TTM operating income has changed by +$42.97 M (+17.97%)